Suchergebnisse - "Baert, Filip"

PubPharm (153)

1

Retrograde Cricopharyngeus Dysfunction, a New Motility Disorder : Single Center Case Series and Treatment Results

enthalten in: Journal of neurogastroenterology and motility | 2024

von Arnaert, S. | Arts, J. | Raymenants, K. | +2

2

Early Versus Late Use of Vedolizumab in Ulcerative Colitis : Clinical, Endoscopic, and Histological Outcomes

enthalten in: Journal of Crohn's & colitis | 2024

von Vermeire, S. | Hanzel, J. | Löwenberg, M. | +38

3

Efficacy of vedolizumab during intravenous induction therapy in ulcerative colitis and Crohn's disease : post hoc analysis of patient-reported outcomes from the VISIBLE 1 and 2 studies

enthalten in: European journal of gastroenterology & hepatology | 2024

von D'Haens, G. | Baert, F. | Danese, S. | +8

4

Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring

enthalten in: Clinical chemistry and laboratory medicine | 2024

von Herroelen, P. | Vanpoucke, H. | Baert, F. | +5

5

Prophylactic versus endoscopy-driven treatment of Crohn's postoperative recurrence : A retrospective, multicentric European study (PORCSE study)

enthalten in: Journal of Crohn's & colitis | 2024

von Geldof, J. | Truyens, M. | Hanssens, M. | +37

CommentIn: J Crohns Colitis. 2024 Apr 20;:. - PMID 38642911

6

Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis : A Belgian Multicenter Cohort Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Lemmens, P. | Louis, E. | Van Moerkercke, W. | +19

7

Baseline Data and Measurement Instruments Reported In Observational Studies In Inflammatory Bowel Disease : Results From A Systematic Review

enthalten in: Journal of Crohn's & colitis | 2024

von Wong, C. | van Oostrom, J. | Pittet, V. | +14

8

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE) : two randomised, double-blind, placebo-controlled, phase 3 studies

enthalten in: Lancet (London, England) | 2023

von Sandborn, W. | Vermeire, S. | Peyrin-Biroulet, L. | +17

CommentIn: Lancet. 2023 Apr 8;401(10383):1132-1133. - PMID 36871570

9

Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease : A European Crohn's and Colitis Organisation [ECCO] Position Paper

enthalten in: Journal of Crohn's & colitis | 2023

von Hanzel, J. | Bossuyt, P. | Pittet, V. | +12

10

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Peyrin-Biroulet, L. | Rahier, J. | Kirchgesner, J. | +120

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]